Human Granulocytic Anaplasmosis - 12/08/11
Doi : 10.1016/j.idc.2008.03.011
Johan S. Bakken, MD, PhD a, b, ⁎ 
, Stephen Dumler, MD c
, Stephen Dumler, MD c a Department of Family Medicine, University of Minnesota Duluth, School of Medicine, 1001 E. Superior Street, Suite L201, Duluth, MN 55202, USA
b St. Luke’s Infectious Disease Associates, 1001 East Superior Street, Suite L201, Duluth, MN 55802, USA
c Division of Medical Microbiology, Department of Pathology, The Johns Hopkins University School of Medicine, 720 Rutland Avenue, Ross 624, Baltimore, MD 21205, USA
Corresponding author. St. Luke’s Infectious Disease Associates, 1001 East Superior Street, Suite L201, Duluth, MN 55802.Abstract |
Tick-borne infections have been recognized in the United States for more than a century. Patients who present with nonspecific fever after exposure to ticks should be evaluated by clinical examination and routine laboratory testing to determine if the illness is potentially a tick-borne infection. This article focuses on the diagnosis and management of human granulocytic anaplasmosis (HGA) caused by Anaplasma phagocytophilum.
Le texte complet de cet article est disponible en PDF.Plan
| This article was supported by grants R01 AI44102 and R56 AI41213. |
© 2008
Elsevier Inc. Tous droits réservés.
Vol 22 - N° 3
P. 433-448 - septembre 2008 Retour au numéro
Article précédent
- What’s New in Rocky Mountain Spotted Fever?
- Luke F. Chen, Daniel J. Sexton
- Tick-Borne Relapsing Fever
- Mark S. Dworkin, Tom G. Schwan, Donald E. Anderson, Stephanie M. Borchardt
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?